<SEC-DOCUMENT>0001776985-26-000041.txt : 20260608
<SEC-HEADER>0001776985-26-000041.hdr.sgml : 20260608
<ACCEPTANCE-DATETIME>20260608080103
ACCESSION NUMBER:		0001776985-26-000041
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20260608
FILED AS OF DATE:		20260608
DATE AS OF CHANGE:		20260608

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BioNTech SE
		CENTRAL INDEX KEY:			0001776985
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			2M
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39081
		FILM NUMBER:		261071072

	BUSINESS ADDRESS:	
		STREET 1:		AN DER GOLDGRUBE 12
		CITY:			MAINZ
		STATE:			2M
		ZIP:			55131
		BUSINESS PHONE:		0049613190840

	MAIL ADDRESS:	
		STREET 1:		AN DER GOLDGRUBE 12
		CITY:			MAINZ
		STATE:			2M
		ZIP:			55131
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>form6-ksharebuyback8june20.htm
<DESCRIPTION>6-K
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="ifb9db686eac44004b718f0064e5e899e_1"></div><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:20pt;font-weight:700;line-height:120%">UNITED STATES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:20pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:20pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:20pt;font-weight:400;line-height:120%"><br></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:20pt;font-weight:700;line-height:120%">FORM 6-K</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a&#8209;16 OR 15d&#8209;16</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">UNDER THE SECURITIES EXCHANGE ACT OF 1934</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">FOR THE MONTH OF JUNE 2026</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">COMMISSION FILE NUMBER 001-39081 </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:20pt;font-weight:700;line-height:120%">BioNTech SE<br></font><font style="color:#333333;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Translation of registrant&#8217;s name into English)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">An der Goldgrube 12</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">D-55131 Mainz</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Germany</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">+49 6131-9084-0<br></font><font style="color:#333333;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20&#8209;F or Form 40&#8209;F&#58; Form 20&#8209;F </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> Form 40&#8209;F </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is submitting the Form 6&#8209;K in paper as permitted by Regulation S&#8209;T Rule 101(b)(1)&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is submitting the Form 6&#8209;K in paper as permitted by Regulation S&#8209;T Rule 101(b)(7)&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:center"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">DOCUMENTS INCLUDED AS PART OF THIS FORM 6-K</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">On June 8, 2026, BioNTech SE (the &#8220;Company&#8221;) provided an update regarding the share repurchase program announced on May 7, 2026, pursuant to which the Company may purchase American Depositary Shares (&#8220;ADSs&#8221;), each representing one ordinary share of the Company, for an aggregate amount of up to $1.0 billion. The Company announced that the buyback period will commence on June 8, 2026, on the U.S. Nasdaq Global Select Market stock exchange and will be conducted within the period up to and including May 6, 2027. The announcement is attached as Exhibit 99.1.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">SIGNATURE</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. </font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.428%"><tr><td style="width:1.0%"></td><td style="width:3.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.492%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.494%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 1.37pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:125%">BioNTech SE</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.37pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:125%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 1.37pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:125%">&#47;s&#47; Ramon Zapata-Gomez</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.37pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:125%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 1.37pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:125%">&#47;s&#47; Dr. Sierk Poetting</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.37pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:125%">Name&#58; Ramon Zapata-Gomez</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.37pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:125%">Name&#58; Dr. Sierk Poetting</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.37pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:125%">Title&#58;   Chief Financial Officer</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.37pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:125%">Title&#58;   Chief Operating Officer</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Date&#58; June 8, 2026</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">EXHIBIT INDEX </font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.905%"></td><td style="width:0.1%"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.37pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Exhibit</font></div></td><td colspan="3" style="padding:2px 1pt 2px 1.37pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Description of Exhibit</font></div></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.37pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:125%">99.1</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:124%;text-decoration:underline"><a href="a991june2026sbbarticle51ma.htm" style="color:#0000ff;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:124%;text-decoration:underline">Disclosure of share buyback program pursuant to Art. 5(1) lit. a) of the Regulation (EU) No. 596&#47;2014 and Art. 2(1) of the Delegated Regulation (EU) 2016&#47;1052</a></font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a991june2026sbbarticle51ma.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i959e65318c2a4fc180b02c27275e6061_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div><img alt="image_0a.jpg" src="image_0a.jpg" style="height:26px;margin-bottom:5pt;vertical-align:text-bottom;width:241px"></div></div><div style="padding-left:0.05pt;text-align:right"><font><br></font></div><div style="padding-left:0.05pt;text-align:right"><font><br></font></div><div style="margin-top:4.6pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:145%">Disclosure of share buyback program pursuant to Art. 5(1) lit. a) of the Regulation (EU) No. 596&#47;2014 and Art. 2(1) of the Delegated Regulation (EU) 2016&#47;1052 </font></div><div style="margin-top:12.45pt;padding-left:0.05pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:145%">MAINZ, Germany, June 8, 2026 -- </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:145%">On May 7, 2026, BioNTech SE (&#8220;BioNTech&#8221;), with the approval of its Supervisory Board and Management Board, authorized a share buyback program of American Depositary Shares (&#8220;ADSs&#8221;) of BioNTech (ISIN&#58; US09075V1026), each representing one ordinary share of BioNTech, with a value of up to USD 1.0 billion (the &#8220;Share Buyback&#8221;). BioNTech expects to use the repurchased ADSs to satisfy obligations in the ordinary course of business and to enhance capital efficiency and maintain financial flexibility. The buyback period will commence on June 8, 2026, on the U.S. Nasdaq Global Select Market stock exchange and will be conducted within the period up to and including May 6, 2027.</font></div><div style="margin-top:0.2pt;padding-left:0.05pt"><font><br></font></div><div style="padding-left:0.05pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:145%">BioNTech will carry out the Share Buyback in accordance with the provisions of Art. 5 of the Regulation (EU) No. 596&#47;2014 of the European Parliament and of the Council of April 16, 2014 (&#8220;MAR&#8221;), and the Delegated Regulation (EU) 2016&#47;1052 of the European Commission of March 8, 2016 with the exception of the restrictions on the purposes specified in Art. 5(2) MAE, and on the basis of the authorization granted by the Annual General Meeting (AGM) of BioNTech on May 17, 2024 (the &#8220;AGM Authorization&#8221;). Pursuant to the AGM Authorization, BioNTech is authorized to acquire treasury shares until May 16, 2029, in accordance with section 71 para. 1 no. 8 of the German Stock Corporation Act (Aktiengesetz, AktG), in an amount of up to 10% of BioNTech&#8217;s share capital existing at the time the authorization resolution is adopted or, if lower, at the time the authorization is exercised. If the shares are repurchased on a stock exchange, the purchase price per share (excluding incidental acquisition costs) shall not exceed the volume-weighted average price of the share during the last three trading days prior to the day of the repurchase by more than 10% and not fall below this price by more than 20%. Therefore, the maximum number of shares that BioNTech is authorized to repurchase under the AGM Authorization is 24.9 million shares. The Share Buyback has also been designed to comply with Rules 10b-18 and 10b5-1 under the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-top:0.5pt;padding-left:0.05pt"><font><br></font></div><div style="padding-left:0.05pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:145%">The Share Buyback will be lead-managed by a credit institution mandated by BioNTech, which will make trading decisions concerning the timing of the purchases of BioNTech&#8217;s shares independently of BioNTech within the meaning of Art. 4(2) lit. b) of the Delegated Regulation (EU) 2016&#47;1052 and BioNTech will not exercise any influence over the credit institution&#8217;s decisions. BioNTech&#8217;s right to terminate the credit institution&#8217;s mandate remains unaffected and the Share Buyback may be stopped and continued at any time in accordance with relevant legal requirements.</font></div><div style="margin-top:0.3pt;padding-left:0.05pt"><font><br></font></div><div style="padding-left:0.05pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:145%">The credit institution shall further comply with all applicable regulatory provisions, in particular, the conditions for trading in Art. 3 of the Delegated Regulation (EU) 2016&#47;1052. Art. 3 requires, inter alia, that shares may not be purchased at a price higher than the higher of the price of the last independent trade and the highest current independent purchase bid on the trading venue where the purchase is carried out. In addition, no more than 25% of the average daily trading volume of the shares at the stock exchange on which the purchase is carried out may be purchased. The average daily trading volume of shares is based on the average daily volume traded in the 20 trading days preceding the date of the relevant purchase.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><img alt="image_0a.jpg" src="image_0a.jpg" style="height:26px;margin-bottom:5pt;vertical-align:text-bottom;width:241px"></div></div><div style="margin-top:0.2pt;padding-left:0.05pt"><font><br></font></div><div style="padding-left:0.05pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:145%">Transactions made under the Share Buyback program will be duly disclosed pursuant to the requirements of Art. 2 para. 3 of the Delegated Regulation (EU) 2016&#47;1052 no later than by the end of the seventh trading day following the date of the execution of the transaction in a detailed form and in an aggregated form. BioNTech will publish the disclosed transactions on its website at </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:145%;text-decoration:underline">https&#58;&#47;&#47;investors.biontech.de&#47;stock-information&#47;share-repurchase</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:145%"> and will keep that information publicly accessible for a period of at least five years from the date of public disclosure.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_0a.jpg
<TEXT>
begin 644 image_0a.jpg
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MFT,>[ ?[O[;F0AN)MW$9_\OE%+N24Y8MV+2<X5")3-B(1N<UDH?GP/@Z^BV
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MB>((L(6?!W:%J&.R)YA,F.H)T#T!YI 9!-E0ATQ#[P188 )?XNY ENC $Y.
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M^>72A?F.I6G.;,8&M*0<Q6B!'V]%I *\PC:CI1,T-&JFXMMUR7E+>#8M"_C
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MF&[3" QHAQ<&CGX\$X>?C?& 8_3JM3]NO'[S!ODHDUNGSYW)^=[$*,V,QS\
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MMF$#CJ$5+"%BX*H^WF*XT3=-ELE<N'+IK:_6<YU:?E$6QR#GFS&)74?/6\*
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MK6E)<D<2FWOXU0'!@9\WD@\WP>KOOUK;D5[?0ZL(SJH.$K %,!&:ZPE0P-Y
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MIQ3()19,B&-LJY)NDE+T2WA0=P]'F9<VKH%/##<+EX_HX=#S>#T8R.YN0PN
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MRO0-]+^U>:7$MB3%+D>],B9L-)2)#3 ]N!X(94;Q\"L^M3P&E/G[QD^Y1/7
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M!5^N9A=J$<?D0A,1[;E-['*%5HRR+7*H:YAV;$'QLC%ME_8DZS;*0&D?7>C
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M'9Y1%7[&U1KG;6,T]DI.GAVUBPY0QM,F=+?&U;0EHG$E@!@4D0\M]B9B],T
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M*;TPK=F[2>&W2@G3$U!&N-[Z;ZX%DLU%58U?)[X_I2%*H<R(4.;]JN5*[\
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MYMWURZ%;SVR3#>83:&Q%B%;T&'DX&F#24$D[[??RC]=5 9N ,/#I7'.#"8B
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.M@4     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
